Gentian Diagnostics ASA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Gentian Diagnostics ASA generated cash of $15,458,000, which is more than the previous year. Cash used in financing activities reached the amount of -$4,598,000 last year. Net change in cash is therefore $6,043,000.
Cash Flow
| 2014 | -1.95M | -2.38M | 4.57M |
|---|---|---|---|
| 2015 | -4.62M | -4.62M | 75.27M |
| 2016 | -7.90M | -4.47M | 20.4M |
| 2017 | -18.63M | -6.90M | 96.53M |
| 2018 | -10.89M | -6.15M | 68.75M |
| 2019 | -21.48M | -4.03M | -1.57M |
| 2020 | -7.66M | -4.57M | -1.51M |
| 2021 | -27.05M | -12.81M | -3.12M |
| 2022 | -13.95M | -14.66M | -4.32M |
| 2023 | 15.45M | -4.87M | -4.59M |
GENT.OL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 81.59M | 114.93M | 157.98M | 171.56M | 198.63M | 146.95M | 75.95M | 67.93M | 1.96M | 1.74M |
Operating activities | ||||||||||
Net income | -10.64M | -23.61M | -24.79M | -17.46M | -39.85M | -19.79M | -15.16M | -8.92M | -3.22M | -2.90M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 9.56M | 10.24M | 7.35M | 6.63M | 6.13M | 3.89M | 3.01M | 2.30M | 1.21M | 860.20K |
Stock-based compensation expense | 3.03M | 3.35M | 4.63M | 3.27M | 1.86M | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 3.03M | 3.35M | 4.63M | 3.27M | 1.86M | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.15M | -3.55M | 1.12M | 860K | 792K | 0 | -3.95M | 0 | -3.23M | 0 |
Inventories | 2.69M | -8.76M | -8.90M | -2.65M | -5.12M | -2.00M | -3.54M | -3.67M | 264.49K | -1.02M |
Accounts payable | -878K | -532K | -833K | 1.20M | 1.31M | 0 | 29.24K | 0 | -503.01K | 0 |
Cash generated by operating activities | 15.45M | -13.95M | -27.05M | -7.66M | -21.48M | -10.89M | -18.63M | -7.90M | -4.62M | -1.95M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -955K | -14.66M | -12.81M | -6.46M | -4.03M | -6.15M | -6.90M | -7.10M | -4.12M | -3.58M |
Acquisitions Net | -390K | 0 | 0 | 1.89M | 0 | 0 | 0 | 3.32M | 0 | 0 |
Cash generated by investing activities | -4.87M | -14.66M | -12.81M | -4.57M | -4.03M | -6.15M | -6.90M | -4.47M | -4.62M | -2.38M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 570K | 462K | 259K | 68.51M | 96.06M | 20.4M | 81.35M | 3.50M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -4.32M | -3.69M | -2.46M | -1.83M | -147.39K | 466.14K | 0 | -6.07M | 0 |
Cash used in financing activities | -4.59M | -4.32M | -3.12M | -1.51M | -1.57M | 68.75M | 96.53M | 20.4M | 75.27M | 4.57M |
Net Change In Cash | 6.04M | -33.33M | -43.04M | -13.58M | -27.06M | 51.68M | 70.99M | 8.02M | 65.97M | 221.26K |
Cash at end of period | 87.64M | 81.59M | 114.93M | 157.98M | 171.56M | 198.63M | 146.95M | 75.95M | 67.93M | 1.96M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |